Ignite Creation Date:
2024-05-06 @ 1:41 AM
Last Modification Date:
2024-10-26 @ 11:08 AM
Study NCT ID:
NCT01873885
Status:
COMPLETED
Last Update Posted:
2014-04-10
First Post:
2013-06-06
Brief Title:
Phase 1 Randomized Double-Blind Placebo-Controlled Exploratory Study That Will Assess the Safety Tolerability Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera PB1046 in Adult Subjects With Stage 1 or 2 Essential Hypertension
Sponsor:
PhaseBio Pharmaceuticals Inc
Organization:
PhaseBio Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Essential Hypertension |
Keywords:
| Name | View |
|---|---|
| PB1046 VIP Essential Hypertension Vasomera | View |